These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34404237)

  • 1. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
    Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
    Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
    Toyoda K; Omae K; Hoshino H; Uchiyama S; Kimura K; Miwa K; Minematsu K; Yamaguchi K; Suda Y; Toru S; Kitagawa K; Ihara M; Koga M; Yamaguchi T;
    Neurology; 2022 Mar; 98(10):e983-e992. PubMed ID: 35074890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Am Heart Assoc; 2019 Aug; 8(15):e012652. PubMed ID: 31347430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com.
    Hoshino H; Toyoda K; Omae K; Takahashi K; Uchiyama S; Kimura K; Yamaguchi K; Minematsu K; Origasa H; Yamaguchi T
    J Atheroscler Thromb; 2023 Jun; 30(6):675-683. PubMed ID: 36070920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials.
    Ahmed M; Ahsan A; Fatima L; Basit J; Nashwan AJ; Ali S; Hamza M; Karalis I; Ahmed R; Alareed A; Ijioma NN; Alraies MC
    Vasc Med; 2024 Oct; 29(5):517-525. PubMed ID: 39164077
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.
    Uchiyama S; Toyoda K; Omae K; Saita R; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T
    J Am Heart Assoc; 2021 Oct; 10(20):e022575. PubMed ID: 34622679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.
    Uchiyama S; Toyoda K; Okamura S; Omae K; Hoshino H; Kimura K; Kitagawa K; Minematsu K; Yamaguchi T
    Int J Stroke; 2023 Apr; 18(4):426-432. PubMed ID: 35762581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.
    Kalantzi K; Tentolouris N; Melidonis AJ; Papadaki S; Peroulis M; Amantos KA; Andreopoulos G; Bellos GI; Boutel D; Bristianou M; Chrisis D; Dimitsikoglou NA; Doupis J; Georgopoulou C; Gkintikas SA; Iraklianou S; Kanellas Κ; Kotsa K; Koufakis T; Kouroglou M; Koutsovasilis AG; Lanaras L; Liouri E; Lixouriotis C; Lykoudi A; Mandalaki E; Papageorgiou E; Papanas N; Rigas S; Stamatelatou MI; Triantafyllidis I; Trikkalinou A; Tsouka AN; Zacharopoulou O; Zoupas C; Tsolakis I; Tselepis AD
    J Am Heart Assoc; 2021 Jan; 10(1):e018184. PubMed ID: 33327737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
    Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS.
    Cui Y; Liu QY; Chen HS
    J Am Heart Assoc; 2024 Sep; 13(18):e036318. PubMed ID: 39248249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack.
    Huang HY; Chen JH; Chi NF; Chen YC
    J Atheroscler Thromb; 2024 Jun; 31(6):904-916. PubMed ID: 38092384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial.
    Toyoda K; Koga M; Tanaka K; Uchiyama S; Sunami H; Omae K; Kimura K; Hoshino H; Fukuda-Doi M; Miwa K; Koge J; Okada Y; Sakai N; Minematsu K; Yamaguchi T;
    Hypertens Res; 2024 Sep; 47(9):2238-2249. PubMed ID: 38977876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Kim W; Kim JS; Rha SW; Choi BG; Jang WY; Kang DO; Park Y; Choi JY; Roh SY; Na JO; Choi CU; Kim EJ; Park CG; Seo HS; Choi SY; Byun JK; Cha J; Oh DJ; Jeong MH;
    Heart Vessels; 2020 Sep; 35(9):1181-1192. PubMed ID: 32270356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack.
    Guan L; Han S; Johnston SC; Bath PM; Amarenco P; Yang Y; Wang T; Jing J; Wang C; Gao Y; Chen W; Yan H; Wang X; Wang Y; Wang Y; Pan Y
    Neurology; 2024 Oct; 103(7):e209845. PubMed ID: 39270151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Trifan G; Gorelick PB; Testai FD
    Circulation; 2021 Jun; 143(25):2441-2453. PubMed ID: 33926204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.